Combined Gene Therapy and Functional Tissue Engineering for the Treatment of Osteoarthritis
<p>The pathogenesis of osteoarthritis is mediated in part by inflammatory cytokines including interleukin-1 (IL-1), which promote degradation of articular cartilage and prevent human mesenchymal stem cell (hMSC) chondrogenesis. We combined gene therapy and functional tissue engineering to deve...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
2016
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10161/12142 |